Congress trades

Encompass Health Corporation (EHC)

NYSE · Healthcare · 14 congress trades · last filed 10 months ago

14
Congress disclosures shown
24d
Median delay on the congress disclosures
of the 45 day limit
7/7
Purchases and sales in the disclosures shown

About Encompass Health Corporation

from the company's filings and listing
Exchange
NYSE
Sector
Healthcare
Industry
Medical - Care Facilities
Chief executive
Mark J. Tarr
Employees
29,699
Listed since
Sep 24, 1986
Market value
$12.1B
Price to earnings
19.5
Earnings per share
$6.29
Dividend yield
0.63%

www.encompasshealth.com

Earnings

6 reported quarters · next on Oct 28, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 5, 2026$1.55$1.48$1.6B$1.6BEPS beatRevenue beat
Q1 FY2026reported Apr 30, 2026$1.60$1.51$1.6B$1.6BEPS beatRevenue in line
Feb 5, 2026$1.46$1.29$1.5B$1.5BEPS beatRevenue in line
Q3 FY2025reported Oct 29, 2025$1.23$1.19$1.5B$1.5BEPS beatRevenue in line
Q2 FY2025reported Aug 5, 2025$1.40$1.23$1.5B$1.4BEPS beatRevenue beat
Q1 FY2025reported Apr 24, 2025$1.37$1.19$1.5B$1.4BEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Apr 7, 2026
ExecutiveSalaryStock awardsOtherTotal
Mark J. TarrPresident and Chief Executive Officer$1.1M$5.3M$3.9M$10.3M
Douglas E. ColtharpExecutive Vice President and Chief Financial Officer$750K$2.0M$1.8M$4.5M
Patrick W. TuerExecutive Vice President and Chief Operating Officer$550K$1.4M$868K$2.8M
Patrick DarbyExecutive Vice President, General Counsel and Secretar$625K$964K$1.1M$2.7M
Elissa J. CharbonneauChief Medical Officer$435K$518K$491K$1.4M

The summary compensation table from the 2025 proxy statement, current executives only. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$1.1B10,484,385-2.6%10.61%
Price T Rowe Associates Inc$511.0M5,055,801+9.9%5.12%
Vanguard Portfolio Management LLC$497.8M4,924,664-0.7%4.98%
Vanguard Capital Management LLC$452.4M4,475,896+0.2%4.53%
Wellington Management Group LLP$331.4M3,278,739-14.8%3.32%
State Street Corp$322.0M3,185,798+1.3%3.22%
Citadel Advisors LLC$259.1M2,563,104+400.7%2.59%
Fuller & Thaler Asset Management, Inc.$248.7M2,460,657+10.3%2.49%
Alliancebernstein L.P.$239.1M2,471,751-5.7%2.50%
Two Sigma Investments, LP$229.2M2,267,668+2.1%2.30%
Geode Capital Management, LLC$191.2M1,890,743-0.4%1.91%
Dimensional Fund Advisors LP$176.2M1,743,028+4.1%1.76%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next EHC filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in EHC

14 disclosures of 14 on record · median 24d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Lisa C. McClainSpouseStockPurchase$1,001 - $15,000+3.0%S&P +12.3% · vs S&P 500 -9.2%Oct 30, 2025Nov 21, 202522d
Lisa C. McClainSpouseStockSale$1,001 - $15,000+6.7%S&P +11.8% · vs S&P 500 -5.0%Oct 31, 2025Nov 21, 202521d
Lisa C. McClainSpouseStockSale$1,001 - $15,000+4.3%S&P +13.2% · vs S&P 500 -9.0%Oct 30, 2025Nov 21, 202522d
Lisa C. McClainSpouseStockPurchase$1,001 - $15,000+11.0%S&P +21.5% · vs S&P 500 -10.4%Jul 22, 2025Aug 13, 202522d
Ro KhannaStockSale$1,001 - $15,000+127.1%S&P +95.6% · vs S&P 500 +31.5%Mar 14, 2023Apr 7, 202324d
Ro KhannaStockPurchase$1,001 - $15,000+96.2%S&P +135.8% · vs S&P 500 -39.6%Sep 23, 2020Oct 21, 202028d
Susie LeeJointStockSale$1,001 - $15,000+84.8%S&P +119.3% · vs S&P 500 -34.6%Aug 27, 2020Oct 7, 202041d
Susie LeeJointStockPurchase$1,001 - $15,000+66.8%S&P +161.4% · vs S&P 500 -94.6%May 19, 2020Jun 15, 202027d
Susie LeeJointStockSale$1,001 - $15,000+88.5%S&P +157.1% · vs S&P 500 -68.5%Jul 31, 2019Aug 29, 201929d
Ro KhannaStockSale$1,001 - $15,000+101.9%S&P +178.4% · vs S&P 500 -76.5%Jun 3, 2019Jul 11, 201938d
Ro KhannaStockSale$1,001 - $15,000+103.5%S&P +172.8% · vs S&P 500 -69.3%May 28, 2019Jun 11, 201914d
Ro KhannaStockPurchase$1,001 - $15,000+94.2%S&P +161.1% · vs S&P 500 -66.8%Apr 23, 2019May 10, 201917d
Ro KhannaStockPurchase$1,001 - $15,000+103.0%S&P +172.0% · vs S&P 500 -69.0%Mar 26, 2019Apr 11, 201916d
Susie LeeJointStockPurchase$1,001 - $15,000+101.5%S&P +170.2% · vs S&P 500 -68.7%Mar 15, 2019Apr 8, 201924d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Questions

Which members of Congress have traded EHC?

Lisa C. McClain, Ro Khanna, Susie Lee disclosed EHC transactions in the filings shown here.

How quickly are EHC trades disclosed?

Congressional disclosures took a median of 24 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days late, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track